The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Activist investor Bill Ackman has filed a request for a special meeting of Allergan shareholders to remove six directors.
Activist investor Bill Ackman has filed a request for a special meeting of Allergan shareholders to remove six directors.
(Pawel Dwulit/THE CANADIAN PRESS)

The wrinkle in Valeant’s pursuit of Allergan

The pursuit of Allergan Inc. is taking on a frantic air.

Perhaps that’s because Valeant Pharmaceuticals International Inc. sees huge untapped value in the Botox maker. More likely, though, it’s because the strategy that has turned the Canadian drug peddler into a stock market superstar is reaching its natural limit.